CBRLAND PHARMA
CBRLAND PHARMA operates in Diversified Metals & Mining.
CBRLAND PHARMA (CBJ) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2024: -0.033x
Based on the latest financial reports, CBRLAND PHARMA (CBJ) has a cash flow conversion efficiency ratio of -0.033x as of June 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-855.66K) by net assets (€26.03 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
CBRLAND PHARMA - Cash Flow Conversion Efficiency Trend (2016–2023)
This chart illustrates how CBRLAND PHARMA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
CBRLAND PHARMA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CBRLAND PHARMA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
HEMOGENYX PHARM.PLC LS-01
F:5HU
|
N/A |
|
CITIC SECURITIES-H-
MU:CI9
|
0.261x |
|
Australis Capital Inc
PINK:AUSAF
|
-0.118x |
|
Hanil Iron & Steel Co. Ltd.
KQ:002220
|
N/A |
|
AdvancedAdvT Ltd
LSE:ADVT
|
0.087x |
|
ALSEA (4FU.SG)
STU:4FU
|
0.135x |
|
New Asia Holdings Inc
PINK:NAHD
|
0.020x |
|
KBG Corp.
KO:318000
|
N/A |
Annual Cash Flow Conversion Efficiency for CBRLAND PHARMA (2016–2023)
The table below shows the annual cash flow conversion efficiency of CBRLAND PHARMA from 2016 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | €29.26 Million | €6.09 Million | 0.208x | -11.37% |
| 2022-12-31 | €35.97 Million | €8.45 Million | 0.235x | +57.84% |
| 2021-12-31 | €42.60 Million | €6.34 Million | 0.149x | +28.87% |
| 2020-12-31 | €46.87 Million | €5.42 Million | 0.116x | +93.09% |
| 2019-12-31 | €51.09 Million | €3.06 Million | 0.060x | +6.81% |
| 2018-12-31 | €55.57 Million | €3.11 Million | 0.056x | +742.00% |
| 2017-12-31 | €63.92 Million | €-557.71K | -0.009x | -212.03% |
| 2016-12-31 | €73.12 Million | €569.48K | 0.008x | -- |